THE TREATMENT OF HYPERTENSION IN WOMEN

被引:42
作者
KAPLAN, NM
机构
关键词
D O I
10.1001/archinte.155.6.563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
More women than men eventually develop hypertension, but they suffer less cardiovascular damage as a consequence. Primary hypertension in women has a greater volume component, often related to commonly associated obesity. Most, lifestyle modifications have more to offer women, but women respond in a similar manner Co various antihypertensive drugs. However, women appear to receive less benefit from antihypertensive therapy, as measured by morbidity and mortality data in multiple large clinical trials. Women who take oral contraceptives typically have a small rise in blood pressure, and in a small percentage, the rise is sufficient to induce hypertension. The prevalence is likely lower with currently used low-dose estrogen formulations. The use of estrogen for postmenopausal replacement therapy almost never raises the blood pressure, so that concerns about hypertension should not interfere with the use of this valuable therapy.
引用
收藏
页码:563 / 567
页数:5
相关论文
共 42 条
[1]   HYPERTENSION IN WOMEN - WHAT IS REALLY KNOWN - THE WOMENS CAUCUS, WORKING GROUP ON WOMENS HEALTH OF THE SOCIETY-OF-GENERAL-INTERNAL-MEDICINE [J].
ANASTOS, K ;
CHARNEY, P ;
CHARON, RA ;
COHEN, E ;
JONES, CY ;
MARTE, C ;
SWIDERSKI, DM ;
WHEAT, ME ;
WILLIAMS, S .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (04) :287-293
[2]   RISKS AND BENEFITS OF REPLACEMENT ESTROGEN [J].
BARRETTCONNOR, E .
ANNUAL REVIEW OF MEDICINE, 1992, 43 :239-251
[3]   POSTMENOPAUSAL ESTROGEN USE AND HEART-DISEASE RISK-FACTORS IN THE 1980S - RANCHO-BERNARDO, CALIF, REVISITED [J].
BARRETTCONNOR, E ;
WINGARD, DL ;
CRIQUI, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (14) :2095-2100
[4]   REMOTE PROGNOSIS OF PREECLAMPSIA IN WOMEN 25 YEARS OLD AND YOUNGER [J].
CARLETON, H ;
FORSYTHE, A ;
FLORES, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 159 (01) :156-160
[5]   HYPERTENSION IN PREGNANCY - DEFINITIONS, FAMILIAL FACTOR, AND REMOTE PROGNOSIS [J].
CHESLEY, LC .
KIDNEY INTERNATIONAL, 1980, 18 (02) :234-240
[6]   ESTROGENS AND HYPERTENSION - EFFECT OF DISCONTINUING ESTROGENS ON BLOOD-PRESSURE, EXCHANGEABLE SODIUM, AND RENIN-ALDOSTERONE SYSTEM [J].
CRANE, MG ;
HARRIS, JJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1978, 276 (01) :33-55
[7]   HYPERTENSION, ORAL CONTRACEPTIVE AGENTS, AND CONJUGATED ESTROGENS [J].
CRANE, MG ;
HARRIS, JJ ;
WINSOR, W .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :13-+
[8]  
CUNNINGHAM FG, 1992, NEW ENGL J MED, V326, P927
[9]   HRT - AN ANALYSIS OF BENEFITS, RISKS AND COSTS [J].
DALY, E ;
ROCHE, M ;
BARLOW, D ;
GRAY, A ;
MCPHERSON, K ;
VESSEY, M .
BRITISH MEDICAL BULLETIN, 1992, 48 (02) :368-400
[10]   IMMUNOREACTIVE RENIN, PRORENIN, AND ENZYMATICALLY ACTIVE RENIN IN PLASMA DURING PREGNANCY AND IN WOMEN TAKING ORAL-CONTRACEPTIVES [J].
DERKX, FHM ;
STUENKEL, C ;
SCHALEKAMP, MPA ;
VISSER, W ;
HUISVELD, IH ;
SCHALEKAMP, MADH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :1008-1015